Neuralink rival Paradromics completes first human implant, plans clinical trials
SMRTR summary
Paradromics, a neurotechnology startup, successfully implanted and removed its brain-computer interface (BCI) device during an epilepsy surgery at the University of Michigan. This 20-minute procedure is a key milestone as the company prepares for broader clinical trials. Paradromics' Connexus BCI system, designed to help people with severe motor impairments communicate through computers, reads signals at the individual neuron level. The company plans to launch a full-scale clinical trial later this year, competing with Neuralink and Synchron in the BCI market.
SMRTR provides this summary for quick context. The original article belongs to Interesting Engineering.
Read the original article